In 2023, we want to hear stories of improved communication and bridging gaps. Of technology used to harness the power of agility. Of process improvements, impediments removal and common goals. About changing attitudes, ways of working and minds. We want to hear stories of failure or win, standing up against change or championing it. What you […]
If you're a data scientist or bioinformatician working in biopharma, here's your chance to explore an advanced and comprehensive way to access and analyze high-quality 'omics data. The QIAGEN OmicSoft […]
Get a first-hand look at QIAGEN’s new Sample to Insight Hereditary solution. By attending this webinar, you will: Learn more about each workflow component. Hear from experts in the field […]
You asked for it by popular demand, and we’re here to deliver. In this training, we’ll cover how antimicrobial resistance (AMR) is used for isolation or can be easily integrated […]
Learn about our Sample to Insight solutions for inherited disorders This year at the European Society for Human Genetics (ESHG) 2023 Annual Meeting, QIAGEN will be at booth #472 premiering our new barrier-breaking Sample to Insight workflow for inherited disease NGS testing—a fast, cheap, ultra-precise panel to report pipeline. Learn more about our products and solutions […]
In this 90-minute training on QIAGEN OmicSoft and Ingenuity Pathway Analysis (IPA), we’ll cover how to easily query inflammatory conditions related to public data (GEO, SRA and more) to: • […]
This 90-minute training will teach you how to easily analyze and interpret RNA-seq data using QIAGEN CLC Genomics Workbench software and QIAGEN Ingenuity Pathway Analysis (IPA). For RNA-seq data, you […]
Verpassen Sie nicht die Gelegenheit, das bestgehütete Geheimnis von somatischen NGS-Tests kennenzulernen. Die von QIAGEN entwickelte neue Datenbank namens HSMD enthält über 2 Jahrzehnte von Experten kuratierte Inhalte aus der […]
Many of you who use QIAGEN Ingenuity Pathway Analysis (IPA) have requested a deeper dive into the IPA core analysis (also known as expression analysis - performed on RNA-seq, scRNA-seq, […]
Automating and scaling a comprehensive genomic profiling workflow can be a tedious and challenging process that requires lots of time and resources. However, an intelligent clinical decision support platform and […]
This webinar will introduce users to the tools available for short reads (Illumina) as well as long reads (Oxford Nanopore, Pac Bio) de novo assembly in QIAGEN CLC Genomics Workbench. […]
Exome experts: Improving the interpretation and integration of exome testing in routine clinical care
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine, […]
Streamline H5N1 and other microbial samples with CLC Genomics Workbench
In this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples. Using viral samples, you will learn how to: […]
Scale up NGS bioinformatics analysis throughput with CLC Genomics Server and Cloud solutions
More and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics […]
Leveraging the power of API-based omics (RNA-seq, proteomics and more) queries for discovery
There is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, expertly curated omics […]
Clinician’s Roundtable: Interpreting genomic test results for precision oncology
You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology […]
QIAGEN Biomedical KB-HD: data- and analytics-driven drug discovery
Ingenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many […]
Network construction and customization with QIAGEN Ingenuity Pathway Analysis
This in-depth training focuses on effectively constructing a network, with or without a dataset (RNA-seq, proteomics, etc.), and easily modifying it – all within Ingenuity Pathway Analysis.
In this interactive training, attendees will learn how to:
• Construct a network from scratch or open a network/pathway of interest from their analysis or the Ingenuity Knowl...
QIAGEN Biomedical KB-HD: data- and analytics-driven drug discovery
Ingenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, a...
Leveraging the power of API-based omics (RNA-seq, proteomics and more) queries for discovery
There is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, exper...
Clinician’s Roundtable: Interpreting genomic test results for precision oncology
You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medici...
Scale up NGS bioinformatics analysis throughput with CLC Genomics Server and Cloud solutions
More and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics Workbench can be ...
Streamline H5N1 and other microbial samples with CLC Genomics Workbench
In this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples.
Using viral samples, you will learn how to:
• Utilize molec...